Brazil approves generic GLP-1 drug sold by Swiss firm Sandoz
Brazil, Canada and India are some of the first countries where the patents to GLP-1 drugs expire. Keystone-SDA…
Savings may not be enough to fund retirement beyond life expectancy: study
According to the study, around half of today’s 65-year-old women will reach the age of 90, whilst men…
The race to launch a pill for weight loss
Researchers have continued to hunt for pills, long considered the holy grail of weight-loss medicine due to the…